MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-04-0073044
Meditell Pharmaceuticals Private Limited
Meditell Pharmaceuticals Private Limited - chemicals in Aurangabad, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹60.98 Lakh
▲ 56% YoY
Net profit · FY 2024
₹63,589
Net margin 1%
EBITDA · FY 2024
₹1.82 Lakh
EBITDA margin 3%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹10,000
Issued & subscribed
Company age
7 yrs
Est. 2019
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Meditell Pharmaceuticals Private Limited
Data last updated:
Meditell Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 26 August 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2019PTC329741. Its GSTIN is 27AAMCM8999F1ZK (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹10,000. It is led by directors Kartik Ganesh Khandelwal and Dinesh Kanhaiyalalji Khandelwal.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C/O Umesh Nandkishor Natani Fl No 04 Kaveri Apt, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2024, the company reported a revenue of ₹60.98 Lakh, a growth of 56% compared to the previous year. For the same year it recorded a net profit of ₹63,589 (net margin 1%) and EBITDA of ₹1.82 Lakh (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 15% over three years.
Meditell Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-04-0073044).
Company details
CIN U24239MH2019PTC329741
Registration Number 329741
Incorporation Date 26 August 2019
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
MSME Classification Micro
Udyam Registration UDYAM-MH-04-0073044
Recognitions & Rankings of Meditell Pharmaceuticals
Contact details
Meditell Pharmaceuticals Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressC/O Umesh Nandkishor Natani Fl No 04 Kaveri Apt, Aurangabad, Maharashtra, India – 431001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Meditell Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Meditell Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Meditell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Meditell Pharmaceuticals Private Limited, buy the company report.
Financials of Meditell Pharmaceuticals Private Limited
FY 2024 filings availableMeditell Pharmaceuticals Private Limited reported revenue of ₹60.98 Lakh (up 56% YoY) for FY 2024.
Revenue · FY 2024
₹60.98 Lakh ▲ 56%
Net profit · FY 2024
₹63,589 margin 1%
EBITDA · FY 2024
₹1.82 Lakh margin 3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 56%
3 years · compounded
▲ 72%
Revenue has grown at a compounded annual rate (CAGR) of 15% over three years, including 56% growth in the latest year. EBITDA rose 56% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.82 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹63,589 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Meditell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Meditell Pharmaceuticals Private Limited
Meditell Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kartik Ganesh Khandelwal | Director | 26 Aug 2019 | 7 Years 2 Months | Current |
| Dinesh Kanhaiyalalji Khandelwal | Director | 26 Aug 2019 | 7 Years 2 Months | Current |
Peer comparison
Meditell Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sirrus Pharmaceuticals Private Limited | ₹61.17 Lakh (FY 2025) | 153.0% | New Delhi, Delhi, India | |||
| S S M Pharmaceuticals Private Limited | ₹61.17 Lakh (FY 2025) | 5.0% | Jaipur, Rajasthan, India | |||
| Aidotick Pharmaceuticals Private Limited | ₹61.08 Lakh (FY 2024) | -60.0% | Ahmedabad, Gujarat, India | |||
| Meditell Pharmaceuticals Private Limitedthis company | ₹60.98 Lakh (FY 2024) | ₹63,589 | 1% | 56.0% | Aurangabad, Maharashtra, India | |
| Million Pharmaceuticals Private Limited | ₹60.92 Lakh (FY 2017) | -2.0% | Muktsar, Punjab, India | |||
| Mednios Pharmaceuticals Private Limited | ₹60.84 Lakh (FY 2025) | 32.0% | Patna, Bihar, India |
To see the full peer comparison of Meditell Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Meditell Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Meditell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Meditell Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCM8999F1ZK | Maharashtra | Active | 15 Oct 2019 |
To see the full GST registrations and return filing status of Meditell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Meditell Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Dinesh Kanhaiyalalji Khandelwal was appointed as Director on 26 Aug 2019.
AGM
Meditell Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Meditell Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Appointed
Dinesh Kanhaiyalalji Khandelwal was appointed as Director.
Appointed
Kartik Ganesh Khandelwal was appointed as Director.
Incorporation
26 Aug 2019
Meditell Pharmaceuticals Private Limited was registered on 26 Aug 2019 with Roc Mumbai & aged 7 years 2 months as per MCA records.
Frequently asked questions
Meditell Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 26 August 2019 (7+ years old) and is registered under CIN U24239MH2019PTC329741.
Meditell Pharmaceuticals has 2 current directors:
- Kartik Ganesh Khandelwal - Director
- Dinesh Kanhaiyalalji Khandelwal - Director
The latest financial statements of Meditell Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Meditell Pharmaceuticals is 27AAMCM8999F1ZK, registered in Maharashtra.
The CIN (Corporate Identification Number) of Meditell Pharmaceuticals is U24239MH2019PTC329741. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Meditell Pharmaceuticals was incorporated on 26 August 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Meditell Pharmaceuticals by revenue are Sirrus Pharmaceuticals Private Limited, S S M Pharmaceuticals Private Limited, Aidotick Pharmaceuticals Private Limited, Million Pharmaceuticals Private Limited, Mednios Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Dinesh Kanhaiyalalji Khandelwal was appointed as Director on 26 Aug 2019. Kartik Ganesh Khandelwal was appointed as Director on 26 Aug 2019.
Yes, Meditell Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-04-0073044).
The registered office of Meditell Pharmaceuticals is at CO Umesh Nandkishor Natani Fl No 04 Kaveri Apt, Aurangabad, Maharashtra, India – 431001.
Meditell Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.